ESMO supports World Cancer Day cautioning that the era of personalised cancer medicine is not here yet
Highlighting the need for more in-depth education and wider collaborations between researchers, oncologists and patients.
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Highlighting the need for more in-depth education and wider collaborations between researchers, oncologists and patients.
It’s time cinema directors realised cancer isn’t always a death sentence, a new study shows
ESMO 2012 emphasises palliative care: 16 new ESMO Designated Centres of Integrated Oncology and Palliative Care honoured New research providing snap-shot of palliative care in Italy
The first ever estimate of the economic burden of cancer in Europe shows that it exceeds 124 billion euros
Studies presented at ESMO 2012 highlight challenges of cancer prevention
Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer, EGFR status may help select patients who will benefit most
Promising new data from trials aimed at delaying resistance to BRAF inhibitors
Landmark global survey reveals major shortcomings in many countries around the world
811 people surveyed by Prof Tejpar and colleagues
Where are the most promising developments from first-in-human studies?
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.